Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Neuroendocrine

Explore clinical trials studying Carcinoma, Neuroendocrine. Study availability and eligibility vary by location and protocol.

230 public trials 42 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Neuroendocrine trial results

Completed

Comparing Radical Surgery and Radical Radiotherapy as First Definitive Treatment for Primary MCC

NCT05253144

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +14 more
Locations
  • University Hospital Birmingham NHS Foundation Trust Birmingham, United Kingdom
  • North Bristol NHS Trust Bristol, United Kingdom
  • Cambridge University Hospitals NHS Foundation Trust Cambridge, United Kingdom
  • NHS Tayside Dundee, United Kingdom
View all 14 locations
View Trial Details
Completed

Avelumab in Participants With Merkel Cell Carcinoma (JAVELIN Merkel 200)

NCT02155647

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +13 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • The Angeles Clinic and Research Institute - West LA Los Angeles, California, United States
  • University of Colorado Aurora, Colorado, United States
  • H. Lee Moffitt Cancer Center and Research Institute, Inc Tampa, Florida, United States
View all 61 locations
View Trial Details
Completed

Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors

NCT01709435

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +30 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital of Orange County Orange, California, United States
  • UCSF Medical Center-Parnassus San Francisco, California, United States
  • UCSF Medical Center-Mission Bay San Francisco, California, United States
View all 23 locations
View Trial Details
Completed

Safety, Efficacy, and Tolerability of BOS172738 in Patients With Advanced Rearranged During Transfection (RET) Gene-Altered Tumors

NCT03780517

Conditions
Adenocarcinoma, Advanced Nonhaematologic Malignancies, Bronchial Neoplasms, +27 more
Locations
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • Institut Jules Bordet Brussels, Belgium
  • UZ Leuven Leuven, Belgium
View all 21 locations
View Trial Details

Related conditions